Remove Bioinformatics Remove Drug Trials Remove Therapies
article thumbnail

Case study: NCI’s Molecular Targets Platform

The Open Targets Blog

Despite the evidence that pediatric cancers could benefit from the same drugs used to treat adult cancers, drug trials are much rarer in children than adults. To Open Targets delivers easy-to-navigate aggregated information and evidence linking therapies, genes, and diseases.

article thumbnail

Personalising whole genome sequencing doubles diagnosis of rare diseases 

Drug Discovery World

They subsequently applied additional bioinformatic approaches, using advanced computer technologies to identify genetic alterations in a patients’ DNA which may be causing disease but had been overlooked during routine testing. . It can also permit targeted screening of known disease complications and access to drug studies.

Disease 130